BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33932587)

  • 1. Effect of preprocedural pharmacologic cardioversion on pulmonary vein isolation in patients with persistent atrial fibrillation.
    Okawa K; Hara S; Morimoto T; Tsushima R; Sudo Y; Sogo M; Ozaki M; Takahashi M; Doi M; Morita H; Ito H
    Heart Rhythm; 2021 Sep; 18(9):1473-1479. PubMed ID: 33932587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Direct Current Synchronized Cardioversion to Ibutilide-Guided Catheter Ablation for Long-Term Sinus Rhythm Maintenance After Isolated Pulmonary Vein Isolation of Persistent Atrial Fibrillation.
    Wang M; Zhao Q; Ding W; Cai S
    Am J Cardiol; 2017 Jun; 119(12):1997-2002. PubMed ID: 28501100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise ablation approach versus pulmonary vein isolation in patients with paroxysmal atrial fibrillation: Randomized controlled trial.
    Faustino M; Pizzi C; Agricola T; Xhyheri B; Costa GM; Flacco ME; Capasso L; Cicolini G; Di Girolamo E; Leonzio L; Manzoli L
    Heart Rhythm; 2015 Sep; 12(9):1907-15. PubMed ID: 26051530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vein activity does not predict the outcome of catheter ablation for persistent atrial fibrillation: A long-term multicenter prospective study.
    Prabhu S; Kalla M; Peck KY; Voskoboinik A; McLellan AJA; Pathik B; Nalliah CJ; Wong GR; Sugumar H; Azzopardi SM; Lee G; Ling LH; Kalman JM; Kistler PM
    Heart Rhythm; 2018 Jul; 15(7):980-986. PubMed ID: 29501669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Left Atrial Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation.
    Yamaguchi T; Tsuchiya T; Nakahara S; Fukui A; Nagamoto Y; Murotani K; Eshima K; Takahashi N
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1055-63. PubMed ID: 27235000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent atrial fibrillation presenting in sinus rhythm: pulmonary vein isolation versus pulmonary vein isolation plus electrogram-guided ablation.
    Sebag FA; Chaachoui N; Linton NW; Amraoui S; Harrison J; Williams S; Rinaldi AC; Gill J; Cooklin M; Kirubakaran S; O'Neill MD; Wright M; Lellouche N
    Arch Cardiovasc Dis; 2013 Oct; 106(10):501-10. PubMed ID: 24070597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the empirical linear ablation and low voltage area-guided ablation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation: a propensity score-matched analysis.
    Suzuki N; Kaneko S; Fujita M; Shinoda M; Kubota R; Ohashi T; Tatami Y; Suzuki J; Hori H; Adachi K; Ito R; Shirai Y; Yanagisawa S; Inden Y; Murohara T
    BMC Cardiovasc Disord; 2022 Jan; 22(1):13. PubMed ID: 35065605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of post-pulmonary vein isolation atrial fibrillation inducibility at redo ablation: Electrophysiological evidence of extra-pulmonary vein substrate progression.
    Johner N; Shah DC; Giannakopoulos G; Girardet A; Namdar M
    Heart Rhythm; 2019 Aug; 16(8):1160-1166. PubMed ID: 30818093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation: The Randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation).
    Fink T; Schlüter M; Heeger CH; Lemes C; Maurer T; Reissmann B; Riedl J; Rottner L; Santoro F; Schmidt B; Wohlmuth P; Mathew S; Sohns C; Ouyang F; Metzner A; Kuck KH
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28687670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience.
    Aryana A; Baker JH; Espinosa Ginic MA; Pujara DK; Bowers MR; O'Neill PG; Ellenbogen KA; Di Biase L; d'Avila A; Natale A
    Heart Rhythm; 2018 Aug; 15(8):1121-1129. PubMed ID: 30060879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes after pulmonary vein isolation plus posterior wall isolation and additional non-pulmonary vein trigger ablation for persistent atrial fibrillation with or without contact force sensing: a propensity score-matched comparison.
    Takamiya T; Nitta J; Inaba O; Sato A; Ikenouchi T; Murata K; Inamura Y; Takahashi Y; Goya M; Hirao K
    J Interv Card Electrophysiol; 2020 Dec; 59(3):585-593. PubMed ID: 31907832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison.
    Pokushalov E; Romanov A; Katritsis DG; Artyomenko S; Shirokova N; Karaskov A; Mittal S; Steinberg JS
    Heart Rhythm; 2013 Sep; 10(9):1280-6. PubMed ID: 23608592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation.
    Miyazaki S; Kuwahara T; Kobori A; Takahashi Y; Takei A; Sato A; Isobe M; Takahashi A
    Europace; 2009 Dec; 11(12):1620-3. PubMed ID: 19910313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation.
    Gaita F; Caponi D; Scaglione M; Montefusco A; Corleto A; Di Monte F; Coin D; Di Donna P; Giustetto C
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):269-75. PubMed ID: 19808418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific outcomes after catheter ablation for persistent AF.
    Segan L; Chieng D; Crowley R; William J; Sugumar H; Ling LH; Hawson J; Prabhu S; Voskoboinik A; Morton JB; Lee G; Sterns LD; Ginks M; Sanders P; Kalman JM; Kistler PM
    Heart Rhythm; 2024 Jun; 21(6):762-770. PubMed ID: 38336190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Efremidis M; Letsas K; Giannopoulos G; Lioni L; Vlachos K; Asvestas D; Karlis D; Kareliotis V; Geladari H; Sideris A; Deftereos S
    Europace; 2015 May; 17(5):741-6. PubMed ID: 25687747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study.
    Derval N; Duchateau J; Denis A; Ramirez FD; Mahida S; André C; Krisai P; Nakatani Y; Kitamura T; Takigawa M; Chauvel R; Tixier R; Pillois X; Sacher F; Hocini M; Haïssaguerre M; Jaïs P; Pambrun T
    Heart Rhythm; 2021 Apr; 18(4):529-537. PubMed ID: 33383226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablation.
    Matsunaga-Lee Y; Inoue K; Tanaka N; Masuda M; Watanabe T; Makino N; Egami Y; Oka T; Minamiguchi H; Miyoshi M; Okada M; Kanda T; Matsuda Y; Kawasaki M; Kawanami S; Ukita K; Kawamura A; Yasumoto K; Tsuda M; Okamoto N; Yano M; Nishino M; Sunaga A; Sotomi Y; Dohi T; Nakatani D; Hikoso S; Sakata Y;
    Heart Rhythm; 2024 Jun; 21(6):733-740. PubMed ID: 38307310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
    Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
    J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.